Innoviva Inc. Files 2025 Proxy Statement
Ticker: INVA · Form: DEF 14A · Filed: Apr 8, 2025 · CIK: 1080014
| Field | Detail |
|---|---|
| Company | Innoviva, INC. (INVA) |
| Form Type | DEF 14A |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: INVA
TL;DR
INVA proxy out - exec comp details and governance updates.
AI Summary
Innoviva, Inc. filed its DEF 14A on April 8, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. Key individuals mentioned include Pavel Raifeld, a member of the board, and the company's former names were Theravance Inc. and Advanced Medicine Inc.
Why It Matters
This filing provides shareholders with crucial information regarding executive pay and company governance, enabling informed voting decisions on important corporate matters.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) providing information to shareholders, not indicating new or significant risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the filing)
- 20250408 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- Innoviva, Inc. (company) — Filer
- Pavel Raifeld (person) — Board Member
- Theravance Inc. (company) — Former Company Name
- Advanced Medicine Inc. (company) — Former Company Name
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When is Innoviva, Inc.'s fiscal year end?
Innoviva, Inc.'s fiscal year ends on December 31st.
Who is mentioned in relation to executive compensation or board membership?
Pavel Raifeld is mentioned as a member of the board, and various compensation-related metrics for 'PeoMember' and 'NonPeoNeoMember' are detailed.
What were Innoviva, Inc.'s previous company names?
Innoviva, Inc. was formerly known as Theravance Inc. and Advanced Medicine Inc.
On what date was this DEF 14A filed?
This DEF 14A filing was made on April 8, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 8, 2025 by Pavel Raifeld regarding Innoviva, Inc. (INVA).